#9 Impact of rosuvastatin on progression of atherosclerosis in people with HIV at moderate cardiovascular risk; a multicentre, randomised, double blind, placebo-controlled trial
Thursday, November 19, 2020 |
2:43 PM - 2:56 PM |
Speaker
Dr Janine Trevillyan
Infectious Diseases Physician, Alfred Health and Senior Lecturer, Monash University
Alfred Health And Monash University
Impact of rosuvastatin on progression of atherosclerosis in people with HIV at moderate cardiovascular risk; a multicentre, randomised, double blind, placebo-controlled trial.
2:43 PM - 2:55 PMBiography
Dr Janine Trevillyan is an infectious diseases physician and researcher who focuses on HIV-associated comorbidities. She trained at the Alfred and Austin Hospitals and completed a PhD through Monash University before undertaking a postdoctoral fellowship at the University of California, Los Angeles.
Speaker
Janine Trevillyan
Infectious Diseases Physician, Alfred Health and Senior Lecturer, Monash University
Alfred Health And Monash University
Support Staff
Linda Starke
Event Coordinator
ASHM
